07-Dec-15 The Chinese medical device market is maturing rapidly, and with it, so is its regulatory presence. Top trends on the horizon for 2016: A move toward localization; research use only loophole closing; imported refurbished products will be a no-no; local bidding for local products; more inspection on the way. [image: MD+DI]

01-Dec-15 At a recent India-Africa summit, Prime Minister Modi discussed working together to improve public health with 54 African heads of state. For India, the main goal is to increase pharmaceutical exports to Africa, while African ministers are keen to copy India’s success in developing drug manufacturing, both to secure their own supplies and to give their economies a fillip. [image: Reuters]

19-Nov-15 Thermo Fisher Scientific has announced the opening of a new GMP facility in Singapore. The new site is intended to meet growing demand for clinical supply services in the region. It will provide pharma and biotech companies with a one-stop service for clinical supplies – including GMP storage, labelling, packaging, comparator sourcing, handling, distribution and returns management. [image: Thermo Fisher Scientific]

09-Nov-15 Chief Minister of Andhra Pradesh, Chandrababu Naidu has taken in-principle decision to develop a dedicated 200 acre industrial park for the manufacture of medical devices in his state. The 200 acre exclusive park will spur domestic production of medical devices, and help reduce import dependency in this sector while creating employment and economic growth. [image: ET Healthworld]

29-Oct-15 The medical contract manufacturer BIT Group has established a second Chinese manufacturing operation in Shenzhen, China, as a joint venture with EDAN Instruments, a Shenzhen-based patient monitoring technology company. “The Chinese medical technology market is expected to grow at double digit rates in the coming years,” said Marius Balger, BIT CEO. [image: Invetech].